公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2004 | A Bayesian noninferiority approach to evaluation of bridging studies | JEN-PEI LIU ; Hsueh, H.; Hsiao, C.-F. | Journal of Biopharmaceutical Statistics | | | |
2011 | A consistency approach to evaluation of bridging studies and multi-regional trials | Tsou, H.-H.; Chien, T.-Y.; JEN-PEI LIU ; Hsiao, C.-F. | Statistics in Medicine | | | |
2003 | A group sequential approach to evaluation of bridging studies | Hsiao, C.-F.; Xu, J.-Z.; JEN-PEI LIU | Journal of Biopharmaceutical Statistics | | | |
2008 | A non-inferiority test for diagnostic accuracy based on the paired partial areas under ROC curves | Li, C.-R.; CHEN-TUO LIAO ; JEN-PEI LIU | Statistics in Medicine | | | |
2009 | A noninferiority test for treatment-by-factor interaction with application to bridging studies and global trials | JEN-PEI LIU | Drug Information Journal | 2 | 2 | |
2008 | A permutation two one-sided tests procedure to detect minimal fold changes of gene expression levels | JEN-PEI LIU ; CHEN-TUO LIAO ; Chiu, S.-T.; Dai, J.-Y. | Journal of Biopharmaceutical Statistics | | | |
2003 | A randomized trial comparing intravesical instillations of mitoxantrone and doxorubicin in patients with superficial bladder cancer | Huang, J.-S.; Chen, W.H.; Lin, C.-C.; Liaw, C.-C.; Wang, C.-H.; Lan, Y.-J.; Lai, C.-H.; JEN-PEI LIU | Chang Gung Medical Journal | | | |
2005 | A two-stage design for bridging studies | Hsiao, C.-F.; Xu, J.-Z.; JEN-PEI LIU | Journal of Biopharmaceutical Statistics | | | |
2008 | A two-stage design for drug screening trials based on continuous endpoints | JEN-PEI LIU | Drug Information Journal | 5 | 5 | |
2016 | Addressing loss of efficiency due to misclassification error in enriched clinical trials for the evaluation of targeted therapies based on the Cox proportional hazards model | Tsai C.-A.; Lee K.-T.; CHEN-AN TSAI ; JEN-PEI LIU | PLoS ONE | 0 | 0 | |
2006 | An Alternative Approach to Evaluation of Poolability for Stability Studies | Liu, Jen-pei ; Tung, Sheng-Che; Pong, Yun-Ming | Journal of Biopharmaceutical Statistics | 5 | 24 | |
2011 | An alternative phase II/III design for continuous endpoints | Huang, W.-S.; JEN-PEI LIU ; Hsiao, C.-F. | Pharmaceutical Statistics | | | |
2014 | An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses | CHEN-AN TSAI ; Huang, C.-Y.; JEN-PEI LIU | Statistics in Medicine | | | |
2013 | An approximate approach to sampling size determination for the equivalence hypothesis | Hsieh, C.-Y.; JEN-PEI LIU | Journal of Biopharmaceutical Statistics | | | |
2012 | An inferential procedure for the probability of passing the USP dissolution test | Chiang, C.; Chen, C.-F.; Huang, M.-Y.; Liu, J.-P.; JEN-PEI LIU ; CHEN-FANG CHEN | Pharmaceutical Statistics | 3 | 2 | |
2013 | Application of the parallel line assay to assessment of biosimilar products based on binary endpoints | Lin, J.-R.; Chow, S.-C.; Chang, C.-H.; Lin, Y.-C.; JEN-PEI LIU | Statistics in Medicine | | | |
2014 | Applications of the Bayesian prior information to evaluation of equivalence of similar biological medicinal products | JEN-PEI LIU | Journal of Biopharmaceutical Statistics | | | |
2006 | Applied Multivariate Quantitative Methods-Canonical Correlation Analysis | Liu, Jen-Pei ; Chie, Wei-Chu | | | | |
2006 | Applied Multivariate Quantitative Methods-Cluster Analysis | Liu, Jen-Pei ; Chie, Wei-Chu | | | | |
2006 | Applied Multivariate Quantitative Methods-Discriminant Analysis | Liu, Jen-Pei ; Chie, Wei-Chu | | | | |